Lifetime Trauma Exposure Accelerates Epigenetic Aging in Midlife Women

Traumatic experiences are remarkably common — a 24-country survey of nearly 69,000 adults (Kessler et al., 2017) found that up to 70% had experienced at least one lifetime trauma — yet the biological pathways through which trauma shortens healthspan remain poorly understood. This study from a University of Pittsburgh-led team directly tested whether cumulative lifetime trauma exposure accelerates epigenetic aging in midlife women, a population largely overlooked in prior epigenetic research that has focused mainly on childhood abuse in mixed-sex or Veteran samples.

The study enrolled 216 women (mean age 59 years; 83% non-Hispanic White, 13% Black, 4% other race/ethnicities). Lifetime trauma was assessed via questionnaires covering a broad range of traumatic events. A subset of 123 women also completed childhood maltreatment measures, enabling separate analysis of childhood abuse subtypes including childhood sexual abuse. Epigenetic age was measured from blood DNA methylation and quantified using four clocks: extrinsic epigenetic age acceleration (EEAA), GrimAge, PC-based PhenoAge (PCPhenoAge), and DunedinPACE. All clock scores were residualized for chronological age and Z-scored before analysis. Linear regression models adjusted for race, education, BMI, and estimated blood cell counts.

The central finding was a dose-response relationship between trauma burden and biological aging. Women with two or more lifetime traumas showed significantly older epigenetic age on GrimAge (B=0.39, SE=0.13, p=0.004) and DunedinPACE (B=0.33, SE=0.11, p=0.003) compared to trauma-unexposed women. Women with exactly one trauma showed a trend toward older epigenetic age on DunedinPACE (B=0.23, SE=0.12, p=0.07) but not GrimAge (B=0.15, SE=0.15, p=0.31), consistent with a cumulative exposure model. The EEAA and PCPhenoAge clocks did not reach significance in the abstract-reported results, suggesting that second-generation and pace-of-aging clocks may be more sensitive to trauma's biological footprint than older-generation tools.

In the childhood maltreatment subsample, childhood sexual abuse specifically was associated with older GrimAge (B=0.56, SE=0.24, p=0.021), representing roughly half a standard deviation difference in epigenetic age — a potentially meaningful magnitude given GrimAge's documented links to mortality and chronic disease outcomes.

Exploratory race-stratified analyses suggested that trauma may disproportionately accelerate epigenetic aging in Black women. The authors explicitly label these analyses as exploratory and sample sizes in subgroups were small, but the pattern is biologically plausible and consistent with the "weathering hypothesis" — which posits that chronic psychosocial stress, including discrimination and cumulative adversity, drives accelerated biological aging in Black Americans at earlier ages than in White Americans. Confirmation in larger, racially diverse samples is warranted.

The study's strengths include the use of four epigenetic clocks spanning multiple generations of clock technology, a well-characterized community sample of midlife women, and the comprehensive assessment of both lifetime and childhood trauma. Key limitations are the modest sample size, cross-sectional design precluding causal inference, and the predominantly White sample reducing generalizability of race-stratified findings. Nonetheless, the convergence of findings across GrimAge and DunedinPACE — two of the most clinically predictive clocks currently available — strengthens confidence in the association.